{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:58:34Z","timestamp":1793656714818,"version":"4.5.1"},"reference-count":12,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Role of FDG PET\/CT in evaluation of biliary tract diseases remains relatively unexplored. PET\/CT with FDG helps in evaluation of both infective \/ inflammatory as well as neoplastic diseases as increased glucose utilization is observed in both the conditions. In this article, we describe the spectrum of FDG PET\/CT findings in various diseases affecting the biliary tract. Role of FDG PET\/CT in neoplastic diseases involving the biliary duct has been described at the time of staging and response evaluation; in characterization of the intrahepatic mass (abscess v\/s cholangiocarcinoma). In addition, we have discussed about the false positive FDG uptake along the biliary duct stent, which interfere with scan interpretation. Few of the benign conditions described are Langerhans cell histiocytosis and IgG4 related disease involving the biliary duct and adenomyomatosis and Xanthogranulomatous cholecystitis involving the gall bladder.<\/jats:p>","DOI":"10.4103\/ijnm.ijnm_5_23","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T12:00:47Z","timestamp":1723896047000},"page":"185-190","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["[18F]FDG PET\/CT in Benign and Malignant Diseases Involving the Biliary Tract"],"prefix":"10.25259","volume":"39","author":[{"given":"Meghana","family":"Prabhu","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Amrita Institute of Medical Sciences, Faridabad, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Nisamudeen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Institute of Liver and Biliary Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Vikas","sequence":"additional","affiliation":[{"name":"Department of Hospital Administration, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"key":"R1-20240902","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/CMAR.S157092","article-title":"Biliary tract cancers:Current knowledge, clinical candidates and future challenges","volume":"11","author":"Tariq","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R2-20240902","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13139-016-0440-y","article-title":"The role of F-18 FDG PET\/CT in intrahepatic cholangiocarcinoma","volume":"51","author":"Lee","year":"2017","journal-title":"Nucl Med Mol Imaging"},{"key":"R3-20240902","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/1450-1147.167605","article-title":"Detection of primary malignancy and metastases with FDG PET\/CT in patients with cholangiocarcinomas:Lesion-based comparison with contrast enhanced CT","volume":"15","author":"Elias","year":"2016","journal-title":"World J Nucl Med"},{"key":"R4-20240902","doi-asserted-by":"crossref","first-page":"768009","DOI":"10.3389\/fonc.2021.768009","article-title":"Biliary tract cancers:Treatment updates and future directions in the era of precision medicine and immuno-oncology","volume":"11","author":"Manne","year":"2021","journal-title":"Front Oncol"},{"key":"R5-20240902","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhep.2019.01.038","article-title":"(18)F-fluorodeoxyglucose positron emission tomography ((18)FDG-PET) for patients with biliary tract cancer:Systematic review and meta-analysis","volume":"71","author":"Lamarca","year":"2019","journal-title":"J Hepatol"},{"key":"R6-20240902","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12149-007-0076-1","article-title":"Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma","volume":"22","author":"Paudyal","year":"2008","journal-title":"Ann Nucl Med"},{"key":"R7-20240902","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.ejso.2020.04.015","article-title":"18-FDG PET-CT should be included in preoperative staging of gall bladder cancer","volume":"46","author":"Goel","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"R8-20240902","doi-asserted-by":"crossref","first-page":"W36","DOI":"10.2214\/AJR.05.1284","article-title":"Adenomyomatosis of the gallbladder:Another cause for a \u201chot\u201d gallbladder on 18F-FDG PET","volume":"189","author":"Maldjian","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"R9-20240902","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.21037\/atm-20-4897","article-title":"A narrative review of gallbladder adenomyomatosis:What we need to know","volume":"8","author":"Lee","year":"2020","journal-title":"Ann Transl Med"},{"key":"R10-20240902","first-page":"119","article-title":"Utility of FDG-PET\/CT in the diagnosis of IgG4-related diseases","volume":"34","author":"Zhao","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"R11-20240902","doi-asserted-by":"crossref","first-page":"e28034","DOI":"10.1002\/pbc.28034","article-title":"FDG PET-CT in pediatric langerhans cell histiocytosis","volume":"67","author":"Jessop","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20240902","first-page":"386","article-title":"18F-FDG PET\/CT in worsening of primary sclerosing cholangitis concomitant with improved langerhans cell histiocytosis","volume":"33","author":"Jain","year":"2014","journal-title":"Rev Esp Med Nucl Imagen Mol"}],"container-title":["Indian Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijnm.ijnm_5_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:38:11Z","timestamp":1779694691000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijnm.co.in\/18ffdg-pet-ct-in-benign-and-malignant-diseases-involving-the-biliary-tract\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijnm.ijnm_5_23","relation":{},"ISSN":["0972-3919","0974-0244"],"issn-type":[{"value":"0972-3919","type":"print"},{"value":"0974-0244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"2023-01-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}